← Mechanisms of action
FCER2
SINGLE PROTEINHomo sapiens
Preferred name: Immunoglobulin epsilon Fc receptor ChEMBL ↗
Linked proteins
Drugs acting on this target (14)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| gomiliximab | Antagonist | experimental | mAb | FCER2 antagonist |
| jyb1904 | Antagonist | experimental | mAb | FCER2 antagonist |
| pf-06444752 | Immunity, active | experimental | Vaccine | FCER2 immunity, active |
| pf-06444753 | Immunity, active | experimental | Vaccine | FCER2 immunity, active |
| al0704rp | Immunity, desensitized | experimental | Biological | FCER2 immunity, desensitized |
| cd23-car-t cells | Immunity, passive | experimental | Cell therapy | FCER2 immunity, passive |
| epsi-gam | Immunity, passive | experimental | Recombinant protein | FCER2 immunity, passive |
| dm-101px | Inhibitor | experimental | Small molecule | FCER2 inhibitor |
| exl-111 | Inhibitor | experimental | Recombinant protein | FCER2 inhibitor |
| gomiliximab | Inhibitor | experimental | mAb | FCER2 inhibitor |
| lp-003 | Inhibitor | experimental | mAb | FCER2 inhibitor |
| r940343 | Inhibitor | experimental | Small molecule | FCER2 inhibitor |
| rp 01 | Inhibitor | experimental | Small molecule | FCER2 inhibitor |
| yh35324 | Inhibitor | experimental | Small molecule | FCER2 inhibitor |